Needham analyst Serge Belanger reiterates Cormedix (NASDAQ:CRMD) with a Buy and maintains $13 price target.
Ride The Rally Or Sell The Rip? Experts React To Stock Market’s Post-Fed Gains
The SPDR S&P 500 ETF Trust (NYSE: SPY) has rallied 2.4% in the last two days after the Federal reserve said on Wednesday that it could begin tapering its $128 billion in monthly asset purchases “soon.”
